Skip to main content

Table 2 Impact of within-day and between day variations on assessment of biochemical and combined risk for Down syndrome

From: The impact of temporal variability of biochemical markers PAPP-A and free β-hCG on the specificity of the first-trimester Down syndrome screening: a Croatian retrospective study

  

Free β-hCG

MoM

PAPP-A

MoM

Biochemical risk

(1 in)

Combined risk

(1 in)

Within-day variations of calculated risk

High risk *

    
 

Mean ± SD

1.87 ± 0.08

0,29 ± 0,01

52.6 ± 6.2

154.4 ± 16.1

 

CV† (%)

4.27

3.45

11.72

10.45

 

Medium risk **

    
 

Mean ± SD

0.59 ± 0,03

0,29 ± 0,01

732.6 ± 76.0

699.9 ± 77.2

 

CV† (%)

5.08

3.45

10.37

11.03

 

Low risk ***

    
 

Mean ± SD

1.87 ± 0.08

1.26 ± 0.05

3060.8 ± 323.5

2527.7 ± 328.3

 

CV† (%)

4.27

3.97

10.57

12.98

 

Human serum

    
 

Mean ± SD

1.47 ± 0.07

1.79 ± 0.06

8668.2 ± 819.4

7313.9 ± 900.9

 

CV† (%)

4.76

3.35

9.45

12.32

Between-day variations of calculated risk

High risk *

    
 

Mean ± SD

1.70 ± 0.09

0.27 ± 0.01

45.39 ± 5.5

145.6 ± 18.2

 

CV† (%)

5.26

3.43

12.12

12.50

 

Medium ris k **

    
 

Mean ± SD

0.59 ± 0.03

0.27 ± 0.01

661.4 ± 68.7

646.1 ± 68.58

 

CV† (%)

4.3

3.43

10.39

11.54

 

Low risk ***

    
 

Mean ± SD

1.70 ± 0.09

1.26 ± 0.05

2442.6 ± 304.6

1993.3 ± 219.7

 

CV† (%)

5.26

4.28

12.47

11.02

 

Human serum

    
 

Mean ± SD

1.36 ± 0.08

1.76 ± 0.09

7446.5 ± 796.8

6146.4 ± 785.4

 

CV† (%)

6.17

5.20

10.70

12.77

  1. *Biochemistry: Control 3 (free β-hCG) + Control 1 (PAPP-A); Patient: 25 years, non-smoker, 67 kg, CRL = 45 mm, NT = 1.5 mm
  2. **Biochemistry: Control 2 (free β-hCG) + Control 1 (PAPP-A); Patient: 25 years, non-smoker, 67 kg, CRL = 45 mm, NT = 1.8 mm
  3. ***Biochemistry: Control 3 (free β-hCG) + Control 2 (PAPP-A); Patient: 25 years, non-smoker, 67 kg, CRL = 45 mm, NT = 1.8 mm
  4. CV† - coefficient of variation